Kim Seung-Ho, Park Soo-Jeong, Lee Jong-Woo, Jin Jong-Youl
Life Science Division, Lab of Protein Engineering, Korea Research Institute of Bioscience and Biotechnology, Taejon, Korea.
J Biochem Mol Biol. 2002 Sep 30;35(5):524-31. doi: 10.5483/bmbrep.2002.35.5.524.
Thrombotic thrombocytopenic purpura (TTP) is characterized by widespread platelet thrombi in arterioles and capillaries. Unusually large or multimeric von Willebrand factor, as well as one or more platelet-agglutinating factors, have been implicated in the pathogenesis of TTP. But, the actual mechanisms of platelet agglutination have not been satisfactorily explained. Recent studies suggested the 37-kDa platelet-agglutinating protein (PAP) p37 to be partially responsible for the formation of platelet thrombi in patients with TTP. We studied mobility in SDS-PAGE, the sequence of N-terminal amino acid residues, DNA and antigenic characteristics of PAP p37, which might be related to the pathogenesis of TTP. PAP p37 was purified from the plasma of a 31-year-old male Korean patient with acute TTP. The findings are as follows: (1) We compared PAP p37 with thrombin through the use of SDS-PAGE, either with or without beta-mercaptoethanol. PAP p37 did not appear to be cleaved between the A- and B-chains of prethrombin 2. However, thrombin did cleave between those of prethrombin 2, but linked with disulfide bridge. (2) N-terminal 21 amino acid sequence of PAP p37 was T-F-G-S-G- E-A-D-X-G-L-R-P-L-F-E-K-K-S-L-E. It appeared to be identical to that of 285-305 amino acid residues of human prothrombin (prethrombin 2). (3) No prothrombin gene DNA mutation was revealed. (4) The antigenicity of PAP p37 was similar to thrombin, which was a result of the competitive binding against the anti-thrombin antibody. With these results, we conclude that PAP p37 has similar characteristics to prethrombin2.
血栓性血小板减少性紫癜(TTP)的特征是小动脉和毛细血管中广泛存在血小板血栓。异常大或多聚体的血管性血友病因子,以及一种或多种血小板凝集因子,被认为与TTP的发病机制有关。但是,血小板凝集的实际机制尚未得到令人满意的解释。最近的研究表明,37 kDa的血小板凝集蛋白(PAP)p37部分负责TTP患者血小板血栓的形成。我们研究了PAP p37在SDS-PAGE中的迁移率、N端氨基酸残基序列、DNA和抗原特性,这些可能与TTP的发病机制有关。PAP p37是从一名31岁患有急性TTP的韩国男性患者的血浆中纯化出来的。结果如下:(1)我们通过使用SDS-PAGE,在有或没有β-巯基乙醇的情况下,将PAP p37与凝血酶进行比较。PAP p37似乎没有在前凝血酶2的A链和B链之间被切割。然而,凝血酶确实在前凝血酶2的A链和B链之间被切割,但通过二硫键连接。(2)PAP p37的N端21个氨基酸序列是T-F-G-S-G-E-A-D-X-G-L-R-P-L-F-E-K-K-S-L-E。它似乎与人凝血酶原(前凝血酶2)的285-305个氨基酸残基的序列相同。(3)未发现凝血酶原基因DNA突变。(4)PAP p37的抗原性与凝血酶相似,这是与抗凝血酶抗体竞争性结合的结果。基于这些结果,我们得出结论,PAP p37具有与前凝血酶2相似的特征。